InvestorsHub Logo
Followers 75
Posts 3281
Boards Moderated 0
Alias Born 03/16/2014

Re: None

Monday, 08/01/2022 4:35:16 AM

Monday, August 01, 2022 4:35:16 AM

Post# of 701062
We are not the first to suffer embargo related nightmares

.... anyone remember how the IMMU nightmare ended ...
I do $21bn buy out PRE REVENUE

Presentation Withdrawn on Embargo Complaint
Immunomedics -15%;
By Cristin Flanagan
(Bloomberg) -- Immunomedics says presentation was cancelled because of a third-party complaint that it had violated the embargo by reporting results presented by its Chairman at an April conference.
CEO says IMMU trying to reverse decision, sees April results reported as different from those in the ASCO abstract submitted last Feb.
“Both we and our many investigators involved are disappointed that our excellent therapeutic results, achieving an interim median survival of about 14 months, may not be presented at this meeting. These results are very encouraging for TNBC patients with metastatic disease who failed multiple prior therapies.”
NOTE: Yday, Immunomedics Falls After ASCO Pulls Presentation on Cancer Drug
IMMU down 15% in pre-mkt on 1.4m vol.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News